Morgan Stanley upgraded Embecta (EMBC) to Equal Weight from Underweight with a price target of $20, up from $13, following the company’s ...

Dynamic Technology Lab Private Ltd lessened its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 6.4% during the 3rd ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...

List today: Embecta Corp. EMBC: This medical device company has seen the Zacks Consensus Estimate for its current year ...

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

On Tuesday, Embecta Corp (NASDAQ:EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents ...

Tandem Diabetes (NASDAQ:TNDM), Stryker (NYSE:SYK), Globus Medical (NYSE:GMED) and Embecta (NASDAQ:EMBC), commenting that it continues to view the medtech sector as attractive moving into 2025.

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Embecta Corporation ( (EMBC) ) has released its Q4 earnings. Here is a breakdown of the information Embecta Corporation presented to its ...

Q4 2024 Earnings Conference Call November 26, 2024 8:00 AM ETCompany ParticipantsPravesh Khandelwal - VP of IRDev Kurdikar ...